MENU
+Compare
NUVB
Stock ticker: NYSE
AS OF
Jun 13 closing price
Price
$1.73
Change
-$0.08 (-4.42%)
Capitalization
588.66M

NUVB Nuvation Bio Forecast, Technical & Fundamental Analysis

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more

NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NUVB with price predictions
Jun 13, 2025

Aroon Indicator for NUVB shows an upward move is likely

NUVB's Aroon Indicator triggered a bullish signal on June 10, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 144 similar instances where the Aroon Indicator showed a similar pattern. In of the 144 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NUVB advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

NUVB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NUVB as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NUVB turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

NUVB moved below its 50-day moving average on June 12, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUVB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.403) is normal, around the industry mean (16.972). P/E Ratio (0.000) is within average values for comparable stocks, (59.618). NUVB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.336). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (47.170) is also within normal values, averaging (257.692).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NUVB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUVB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NUVB is expected to report earnings to -15 cents per share on August 06

Nuvation Bio NUVB Stock Earnings Reports
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Missed
by $1.83
The last earnings report on May 07 showed earnings per share of -15 cents, missing the estimate of -15 cents. With 8.96M shares outstanding, the current market capitalization sits at 588.65M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1500 Broadway
Phone
+1 332 208-6102
Employees
51
Web
https://www.nuvationbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTGFX29.17N/A
N/A
Templeton Growth R6
SCRYX11.62N/A
N/A
AB Small Cap Core Advisor
NWXRX11.69N/A
N/A
Nationwide Small Cap Index Instl Svc
ACWZX17.50N/A
N/A
AMG GW&K Small/Mid Cap Growth Z
JNMCX15.23-0.20
-1.30%
Janus Henderson Mid Cap Value D

NUVB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-4.42%
BEAM - NUVB
47%
Loosely correlated
-2.18%
XNCR - NUVB
46%
Loosely correlated
-2.55%
TRDA - NUVB
46%
Loosely correlated
-3.31%
ERAS - NUVB
46%
Loosely correlated
-3.27%
MNMD - NUVB
45%
Loosely correlated
-1.78%
More